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Data from France and the UK showed a disproportionately higher prevalence of obesity in patients 
with COVID-19 admitted to Intensive Care Units (ICU) compared to general population data (1, 2). 
Approximately 10% of ICU patients in the UK have a BMI ≥40 kg/m2 and evidence shows 
increased mortality amongst this group (2, 3). The UK Government advice for those with a BMI ≥40 
kg/m2 is to be ‘particularly stringent following social distancing measures’. This has created 
confusion and fear amongst many people living with obesity due to an uncertainty about their risk 
or what actions they should take, including those with a BMI ≥30 kg/m2, who are also over-
represented in ICU, but not listed as ‘at risk’ (3). 
We consulted with people living with obesity and here, we summarise the main reflections, 
formulated into a call for action (see supplement material and Table 1). It is a candid account of the 
impact of COVID-19 during the peak of the pandemic in the UK. Reported effects were both 
physical and mental and are likely to have a lasting impact for many years to come. 
Overwhelmingly, we heard of genuine, all-consuming fears of contracting COVID-19, with many 
people afraid of not getting medical support if they are admitted to hospital and the accumulating 
reports that they are at greater risk of dying. Clearly, there is an immediate need for clarity 
regarding risk, both in terms of contracting the virus and for its likely impact.  .   
There was considerable anxiety about the capacity of the healthcare system to provide appropriate 
equipment, gowns and beds.  Anxiety about accessing healthcare is not a new phenomenon (4) 
but is likely to be exposed during the current crisis.  From the perspective of Obesity UK and 
Obesity Empowerment Network (OEN) members, this not only represents a physical challenge, but 
one of dignity if they become hospitalised. These fears are not without cause; patients who require 
sedation do need to be moved and proning appears to be important in the successful treatment of 
acute respiratory distress (5).  There is also a fear that access to obesity treatments (particularly 
NHS multidisciplinary therapy and bariatric surgery) will be affected by austerity policies in 
response to the economic crisis at a time of increased demand . 
Another recurring theme was stigma,  largely related to comments  on social media and fuelled by 
the media. We suggest that media speculation is underpinned  by societal norms permitting the 




discussion and referencing of  body shape and size    by anyone; perpetuating existing stigma.  
Many expressed that this  led to feelings of shame,   a perception of being “less of a priority than 
any other condition” and a reluctance to seek help. Respondents were acutely aware of the impact 
that language has on stigma, with many citing the poor use of “unscientific” words. This is not new 
to COVID-19 but has been exacerbated during this time (6).  Stigma has a lasting and negative 
impact on the mental and physical health of people living with obesity (7).  It can be conscious or 
unconscious and delivered from multiple sources including health professionals  (6). One 
consequence can be an avoidance of healthcare; likely worsening COVID-19 outcomes. Obesity 
UK, some Royal Colleges, charities, advocacy groups, clinicians and patients have been striving 
hard for many years to reduce weight stigma and guidance and position statements are available 
(6, 8).   
In every response, we learnt about mental health concerns.  Though some of these were  linked to 
the fear of contracting COVID-19, many related to the impact of isolation, shielding or social 
distancing.  Resilience appears to relate to mental health prior to lock-down; those who reported 
coping better often expressed that they were in a “good place mentally” before COVID-19 
outbreak. Worryingly,  this is not the case for many, particularly those who have recently 
undergone (or are waiting for) bariatric surgery.  Lock-down presents substantial challenges to 
maintaining healthy behaviours for anyone; however, people living with obesity have often 
experienced years battling with weight and experiencing feelings of guilt from perceived failure (9).  
Representatives in our consultation reported having a fear of weight gain during lock-
down,expressed through the impact of anxiety on eating behaviours (often compounded by 
scrutiny from family members). For many, this related to stigma or shame, also preventing them 
from exercising or shopping for food in ways that did not make them feel self-conscious. Lock-
down has had a profound influence on self-efficacy, and increased episodes of secret eating or 
binge eating has been commonly reported within the Obesity UK support groups during this time. 
Like many stigmatised populations, people living with obesity have often developed  coping 
strategies over many years (10) and this was highlighted in our consultation.  Many reported using 




focused and dedicated approaches to protect physical and mental health, including attending 
remote support groups.   
Our calls for action are thus: Immediate action is needed to clarify the risk of adverse COVID-19 
outcomes for people living with obesity, with specific recommendations for those at greatest risk 
and the healthcare professionals who support them. This includes supporting research to define 
the risk of infection and subsequent mortality in people living with obesity, in addition to providing 
clear guidance on managing risk. Essential to this is careful consideration of messaging to prevent 
the perpetuation and exacerbation of stigma.   Long-term, the current pandemic offers an 
opportunity to consider ways to improve the healthcare system for people living with obesity and 
tackle obesity related stigma.  In addition to providing appropriate equipment, we advocate specific 
training for health care professionals which empowers them to support people living with obesity, 
minimise unconscious bias and prevent stigma  While we welcome the recent UK Government 
focus on obesity, any action must be considered in the context of the experiences of people living 
with obesity and an understanding of obesity as a complex chronic disease.  Accordingly, we call 
on the UK Governments to work with people living with obesity when developing guidance and 
COVID-19 recovery plans, who are in frequent contact with the healthcare system and have 
expertise on barriers to accessing healthcare (6)..  
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The idea was conceived by SLB and MB. SLB led the promotion and gathering of feedback from 
patient and population groups, supported by KC, PC and AH.  SLB, KC, PC, AH and MB 
interpreted the feedback.  All authors contributed to writing the paper, including ensuring data were 
relevant and up to date. 
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